Javascript must be enabled to continue!
Epigenetic Modulation of ESR1 and DNMT3A Following Finasteride Exposure: Implications for Female Reproductive Function
View through CrossRef
Estrogen receptor 1 (ESR1) plays a central role in female reproductive function by mediating estrogen-dependent regulation of follicular maturation, ovulation, and endometrial preparation for implantation. Dysregulation of ESR1 has been associated with impaired fertility. Similarly, DNA methyltransferase 3A (DNMT3A), a key enzyme in establishing DNA methylation patterns, is essential for oocyte development and proper genomic imprinting. Alterations in DNMT3A activity can compromise oocyte quality and early embryonic development. Finasteride, a 5-alpha reductase inhibitor commonly prescribed for androgenic alopecia and benign prostatic hyperplasia in men, is also used off-label in women for conditions such as hirsutism, acne, and alopecia. Although its endocrine effects are well characterized, its potential epigenetic influence on reproductive signaling pathways remains insufficiently explored. In this study, we investigated the epigenetic impact of finasteride on gonadal signaling pathways using Sertoli cell models. Differential methylation analyses identified multiple genes exhibiting altered epigenetic profiles following finasteride exposure. Notably, ESR1 and DNMT3A were among the dysregulated genes, along with several downstream targets including FAM50B, SNRPN, SMRP1, AP-1, G-protein–related genes, CALML4, PLAG1, SIRT1, SPAG4, and AMPK. These findings suggest that finasteride may influence reproductive-related pathways through epigenetic modulation of ESR1, DNMT3A, and their associated gene networks. While these results do not establish direct causality, they highlight the need for further research to determine whether finasteride may contribute to reproductive dysfunction or infertility in women through epigenetic mechanisms.
This abstract was presented at the American Physiology Summit 2026 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
Title: Epigenetic Modulation of ESR1 and DNMT3A Following Finasteride Exposure: Implications for Female Reproductive Function
Description:
Estrogen receptor 1 (ESR1) plays a central role in female reproductive function by mediating estrogen-dependent regulation of follicular maturation, ovulation, and endometrial preparation for implantation.
Dysregulation of ESR1 has been associated with impaired fertility.
Similarly, DNA methyltransferase 3A (DNMT3A), a key enzyme in establishing DNA methylation patterns, is essential for oocyte development and proper genomic imprinting.
Alterations in DNMT3A activity can compromise oocyte quality and early embryonic development.
Finasteride, a 5-alpha reductase inhibitor commonly prescribed for androgenic alopecia and benign prostatic hyperplasia in men, is also used off-label in women for conditions such as hirsutism, acne, and alopecia.
Although its endocrine effects are well characterized, its potential epigenetic influence on reproductive signaling pathways remains insufficiently explored.
In this study, we investigated the epigenetic impact of finasteride on gonadal signaling pathways using Sertoli cell models.
Differential methylation analyses identified multiple genes exhibiting altered epigenetic profiles following finasteride exposure.
Notably, ESR1 and DNMT3A were among the dysregulated genes, along with several downstream targets including FAM50B, SNRPN, SMRP1, AP-1, G-protein–related genes, CALML4, PLAG1, SIRT1, SPAG4, and AMPK.
These findings suggest that finasteride may influence reproductive-related pathways through epigenetic modulation of ESR1, DNMT3A, and their associated gene networks.
While these results do not establish direct causality, they highlight the need for further research to determine whether finasteride may contribute to reproductive dysfunction or infertility in women through epigenetic mechanisms.
This abstract was presented at the American Physiology Summit 2026 and is only available in HTML format.
There is no downloadable file or PDF version.
The Physiology editorial board was not involved in the peer review process.
Related Results
DNMT3A expression Analysis in AML
DNMT3A expression Analysis in AML
Abstract
Introduction
DNA methyltransferase 3A (DNMT3A) is one of two human de novo DNA methyltransferases essential for the regulation of gene expres...
DNA methyltransferase 3A: A prognostic biomarker and potential target for immunotherapy in gastric cancer
DNA methyltransferase 3A: A prognostic biomarker and potential target for immunotherapy in gastric cancer
DNA methyltransferase 3A (DNMT3A) has been associated with the occurrence or progression of various tumors, including gastric cancer. However, the role of DNMT3A in the efficacy of...
Global Online Interest in Finasteride Sexual Side Effects
Global Online Interest in Finasteride Sexual Side Effects
Abstract
Prior literature has suggested that Propecia or finasteride may negatively impact men’s sexual health. In 2011, the Food and Drug Administration (FDA) provided a w...
Abstract S3-05: Patient-derived xenograft study reveals endocrine therapy resistance of ER+ breast cancer caused by distinct ESR1 gene aberrations
Abstract S3-05: Patient-derived xenograft study reveals endocrine therapy resistance of ER+ breast cancer caused by distinct ESR1 gene aberrations
Abstract
Endocrine therapy resistance occurs in 50% of estrogen receptor positive (ER+) luminal breast cancers but the underlying mechanisms are poorly understood. T...
Finasteride and Suicide: A Postmarketing Case Series
Finasteride and Suicide: A Postmarketing Case Series
<b><i>Background:</i></b> In 2011, depression was added to the product labeling of finasteride in the USA. The US Food and Drug Administration’s Adverse Eve...
COMPARITIVE STUDY OF TOPICAL MINOXIDIL (5%) PLUS FINASTERIDE (0.1%) VERSUS PLATELET-RICH PLASMA PLUS TOPICAL MINOXIDIL (5%) PLUS FINASTERIDE (0.1%) IN PATIENTS WITH ANDROGENIC ALOPECIA
COMPARITIVE STUDY OF TOPICAL MINOXIDIL (5%) PLUS FINASTERIDE (0.1%) VERSUS PLATELET-RICH PLASMA PLUS TOPICAL MINOXIDIL (5%) PLUS FINASTERIDE (0.1%) IN PATIENTS WITH ANDROGENIC ALOPECIA
Objective: Androgenic alopecia is progressive loss of terminal hairs in patterned distribution. It causes psychoemotional problems and affects the quality of life. Therefore, to ac...
Persistent Sexual Side Effects of Finasteride: Could They be Permanent?
Persistent Sexual Side Effects of Finasteride: Could They be Permanent?
ABSTRACT
Introduction
Finasteride has been associated with sexual side effects that may persist despite discontinuation of the m...
Possible Role of Osteopathic Manipulation Treatment in Alleviation of
Finasteride-Induced Dementia through Modulation of HOMER-3 Gene
Methylation
Possible Role of Osteopathic Manipulation Treatment in Alleviation of
Finasteride-Induced Dementia through Modulation of HOMER-3 Gene
Methylation
Homer-3 gene is associated with neurological disorders that can affect
cognitive function, including dementia. It is a protein that regulates AMPAR
...

